Neuland Laboratories Ltd
₹19955
-245 (1.21%)
Thu, 22 Oct 2026, 05:22 pm
Neuland Laboratories News
US FDA signals closure of Neuland Labs Unit 3 inspection
The US FDA has signalled the closure of its inspection of Unit 3 of Neuland Laboratories, marking a key regulatory development for the pharmaceutical company.
14 Oct 2026
companies
Neuland Laboratories shares flag large-trade signal
A large-trade signal flagged approximately 16,535 shares of Neuland Laboratories changing hands on NSE at ₹21,985.00, with a combined value of ₹36.35 crore.
24 Sept 2026
equity-markets
Neuland Labs to host analysts at Goldman Sachs event
Neuland Laboratories Ltd management will participate in the Goldman Sachs Global Healthcare CDMO Day in Singapore from September 23-25, 2026. The event includes group and one-on-one meetings.
16 Sept 2026
companies
Neuland Laboratories to meet analysts on September 23
Neuland Laboratories has scheduled a meeting with analysts and investors on September 23, providing stakeholders an opportunity to engage with the company's management.
16 Sept 2026
companies
Neuland Labs Co-MD focuses on pharma partnerships
Neuland Laboratories' Co-MD aims to strengthen partnerships with top pharma and biotech firms to meet customer needs over the next decade.
15 Sept 2026
companies
Market Current News
Khazanchi Jewellers Limited
Khazanchi Jewellers gets in-principle approval for main board migration
Khazanchi Jewellers Limited received in-principle approval from BSE and NSE to migrate from the SME platform to the Main Board. The approvals are valid for 45 days.
21 Oct 2026
ipo
Core4 Engineers SME IPO: ₹285 Cr Order Book
Core4 Engineers Limited files DRHP for SME IPO. The Mysore-based EPCC firm reports ₹91.34 Cr FY26 revenue and a ₹285.83 Cr order book, seeking funds for working capital.
21 Oct 2026
ipo
SFC Env Tech IPO: ₹150 Cr Fresh Issue
SFC Environmental Technologies files DRHP for a ₹150 crore fresh issue. The Navi Mumbai-based firm holds 80% market share in SBR technology with FY26 revenue at ₹803.63 crore.
21 Oct 2026
ipo
EAAA India Alternatives IPO: ₹1,200 Cr OFS
EAAA India Alternatives files DRHP for a ₹1,200 crore Offer for Sale. No fresh issue; proceeds go to promoters. AUM stands at ₹953,448.78 million.
21 Oct 2026
ipo
Paras Healthcare IPO Day 1: Demand Sluggish at 0.08x
Paras Healthcare IPO saw weak response on Day 1 with overall subscription at 0.08x. Retail led demand at 0.41x, while QIB interest remained nil.
21 Oct 2026
ipo